BioSpace News Archive

Imvax, Inc. today announced details of its two poster presentations at the 2023 Society for NeuroOncology (SNO) 28th Annual Meeting, which was held in Vancouver, British Columbia, Canada, from November 15-19, 2023.

Tempest Therapeutics, Inc. announced that management will participate in a fireside chat at the 35th Annual Piper Sandler Healthcare Conference on Tuesday, November 28, 2023 at 3:00 p.m. ET.

Daré Bioscience, Inc. and Premier Research International, LLC announced that the companies extended their partnership agreement under which Premier Research will continue to provide on an exclusive basis contract research organization services within the United States to support the clinical development of Daré’s reproductive health portfolio.

Cidara Therapeutics, Inc. announced that it has been named a Top Workplace by The San Diego Union-Tribune.

Akebia Therapeutics, Inc. announced that John Butler, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28th at 10:30 a.m. EST.

Ashvattha Therapeutics announced that members of its senior management team will participate in two upcoming ophthalmology conferences.

Orsini Specialty Pharmacy has been selected by Takeda Pharmaceuticals as the exclusive specialty pharmacy partner for ADZYNMA (ADAMTS13, recombinant-krhn).

Battelle, Andelyn Biosciences, Inc. , and AmplifyBio, have been awarded a new task order from the National Institute of Neurological Disorders and Stroke (NINDS) to manufacture suspension process gene therapy for the transformative treatment of Aspartylglucosaminuria (AGU).

The U.S. clinical oncology next generation sequencing market size was estimated at USD 166.9 million in 2022 and is expected to surpass around USD 687.04 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 15.2% during the forecast period 2023 to 2032.

The global artificial intelligence (AI) in biopharmaceutical market size was valued at USD 0.86 billion in 2022 and is projected to surpass around USD 14.07 billion by 2032, expanding at a remarkable CAGR of 32.3% from 2023 to 2032.